U.S. flag

An official website of the United States government

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Links from GEO Profiles

Items: 1 to 20 of 186

1.
Diacylglycerols and Lysophosphatidic Acid, Enriched on Lipoprotein(a), Contribute to Monocyte Inflammation
Kim E. Dzobo, Arjen J. Cupido, Barend M. Mol, Lotte C.A. Stiekema, Miranda Versloot, Maaike Winkelmeijer, Jorge Peter, Anne-Marije Pennekamp, Stefan R. Havik, Frédéric M. Vaz, Michel van Weeghel, Koen H.M. Prange, Johannes H.M. Levels, Menno P.J. de Winther, Sotirios Tsimikas, Albert K. Groen, Erik S.G. Stroes, Dominique P.V. de Kleijn, Jeffrey Kroon
Arterioscler Thromb Vasc Biol. 2024 Mar; 44(3): 720–740. Published online 2024 Jan 25. doi: 10.1161/ATVBAHA.123.319937
PMCID:
PMC10880937
AbstractArticlePDF–2.9M
2.
Confounding Factors Responsible for Elevated Lp(a) Levels in Patients with Coronary Artery Disease
Navaneeth Amin, Tom Devasia, Shobha Ullas Kamath, Ganesh Paramasivam, Prasad Narayana Shetty, Ajit Singh, Ganesha N. S. Prakash
Ann Card Anaesth. 2024 Jan-Mar; 27(1): 32–36. Published online 2024 Jan 12. doi: 10.4103/aca.aca_88_23
PMCID:
PMC10876127
AbstractArticlePDF–750K
3.
Haplotype of the Lipoprotein(a) Gene Variants rs10455872 and rs3798220 Is Associated with Parameters of Coagulation, Fibrinolysis, and Inflammation in Patients after Myocardial Infarction and Highly Elevated Lipoprotein(a) Values
Sabina Ugovšek, Andreja Rehberger Likozar, Tina Levstek, Katarina Trebušak Podkrajšek, Janja Zupan, Miran Šebeštjen
Int J Mol Sci. 2024 Jan; 25(2): 736. Published online 2024 Jan 6. doi: 10.3390/ijms25020736
PMCID:
PMC10815733
AbstractArticlePDF–2.3M
4.
Predictive value of lipoprotein(a) for left atrial thrombus or spontaneous echo contrast in non-valvular atrial fibrillation patients with low CHA2DS2-VASc scores: a cross-sectional study
Kamila Kamili, Tingting Zheng, Chaodi Luo, Xuan Wang, Gang Tian
Lipids Health Dis. 2024; 23: 22. Published online 2024 Jan 22. doi: 10.1186/s12944-023-01990-1
PMCID:
PMC10801929
AbstractArticlePDF–1.3M
5.
Association of lipoprotein(a) with left ventricular hypertrophy assessed by electrocardiogram in adults: a large cross-sectional study
Xuejiao Yan, Jing Gong, Zhenwei Wang, Fangfang Wang, Chunjian Qi
Front Endocrinol (Lausanne) 2023; 14: 1260050. Published online 2023 Nov 30. doi: 10.3389/fendo.2023.1260050
PMCID:
PMC10720892
AbstractArticlePDF–1.2M
6.
Lipoprotein(a) and calcific aortic valve disease initiation and progression: a systematic review and meta-analysis
Panteleimon Pantelidis, Evangelos Oikonomou, Stamatios Lampsas, Georgios E Zakynthinos, Antonios Lysandrou, Konstantinos Kalogeras, Efstratios Katsianos, Panagiotis Theofilis, Gerasimos Siasos, Michael Andrew Vavuranakis, Alexios S Antonopoulos, Dimitris Tousoulis, Manolis Vavouranakis
Cardiovasc Res. 2023 Jun; 119(8): 1641–1655. Published online 2023 Apr 20. doi: 10.1093/cvr/cvad062
PMCID:
PMC10702855
AbstractArticlePDF–1.0M
7.
Association of the LPA gene polymorphisms with coronary artery disease risk in the Xinjiang population of China: A case–control study
Yi-Wen Liu, Chun-Lan Dong, Xue Jiang, Deng-Yao Liu
Medicine (Baltimore) 2023 Dec 1; 102(48): e36181. Published online 2023 Dec 1. doi: 10.1097/MD.0000000000036181
PMCID:
PMC10695570
AbstractArticlePDF–515K
8.
Serum lipoprotein(a) and reclassification of coronary heart disease risk; application of prediction in a cross-sectional analysis of an ongoing Iranian cohort
Mojgan Ghavami, Alireza Abdshah, Sadaf Esteghamati, Nima Hafezi-Nejad, Manouchehr Nakhjavani, Alireza Esteghamati
BMC Public Health. 2023; 23: 2402. Published online 2023 Dec 2. doi: 10.1186/s12889-023-17332-w
PMCID:
PMC10693688
AbstractArticlePDF–1.3M
9.
Lipoprotein (a) as a predictor of diabetic retinopathy in patients with type 2 diabetes: A systematic review
Mohammad Sadra Gholami Chahkand, Fatemeh Esmaeilpour Moallem, Abolfazl Qezelgachi, Kiana Seifouri, Armin Pesaran Afsharian, Farzad sheikhzadeh, Atefe poursalehi, Fateme Sadat Fani Sadrabadi, Mehrnush Saghab Torbati, Mohaddese Ramezanzade, Goharsharieh Alishiri, Arina Ansari, Emad Zare Dehabadi, Saeed Karimi Matloub, Zahra Sheikh, Niloofar Deravi, Saba Mehrtabar, Fatemeh Chichagi, Neda Faal Hamedanchi, Mohammadreza Arzaghi, Mahla Asadi, Parisa Alsadat Dadkhah, Akram Ansari
Diab Vasc Dis Res. 2023 Nov-Dec; 20(6): 14791641231197114. Published online 2023 Nov 28. doi: 10.1177/14791641231197114
PMCID:
PMC10685788
AbstractArticlePDF–697K
10.
Association between lipoprotein(a) and insulin resistance in Chinese adults: results from the China health and nutrition survey
Heng Wang, Jia-Li Fan
Front Endocrinol (Lausanne) 2023; 14: 1234140. Published online 2023 Oct 9. doi: 10.3389/fendo.2023.1234140
PMCID:
PMC10591330
AbstractArticlePDF–1.6M
11.
Lipoprotein(a) as a Risk Factor for Cardiovascular Diseases: Pathophysiology and Treatment Perspectives
Pierandrea Vinci, Filippo Giorgio Di Girolamo, Emiliano Panizon, Letizia Maria Tosoni, Carla Cerrato, Federica Pellicori, Nicola Altamura, Alessia Pirulli, Michele Zaccari, Chiara Biasinutto, Chiara Roni, Nicola Fiotti, Paolo Schincariol, Alessandro Mangogna, Gianni Biolo
Int J Environ Res Public Health. 2023 Sep; 20(18): 6721. Published online 2023 Sep 6. doi: 10.3390/ijerph20186721
PMCID:
PMC10531345
AbstractArticlePDF–1.1M
12.
Lipoprotein(a): Just an Innocent Bystander in Arterial Hypertension?
Gabriele Brosolo, Andrea Da Porto, Stefano Marcante, Alessandro Picci, Filippo Capilupi, Patrizio Capilupi, Luca Bulfone, Antonio Vacca, Nicole Bertin, Cinzia Vivarelli, Jacopo Comand, Cristiana Catena, Leonardo A. Sechi
Int J Mol Sci. 2023 Sep; 24(17): 13363. Published online 2023 Aug 29. doi: 10.3390/ijms241713363
PMCID:
PMC10487946
AbstractArticlePDF–2.3M
13.
Lipoprotein(a) is a new prognostic factor in patients with psoriasis and coronary artery disease: a retrospective cohort study
Lin Zhao, Lin Sun, ZengLei Zhang, KunQi Yang, ZuoZhi Li, Man Wang, Yan Zeng, XianLiang Zhou, WeiXian Yang
Lipids Health Dis. 2023; 22: 141. Published online 2023 Sep 2. doi: 10.1186/s12944-023-01901-4
PMCID:
PMC10474627
AbstractArticlePDF–1.7M
14.
Lipoprotein(a) is associated with a larger systemic burden of arterial calcification
Sunny S Singh, Janine E van der Toorn, Eric J G Sijbrands, Yolanda B de Rijke, Maryam Kavousi, Daniel Bos
Eur Heart J Cardiovasc Imaging. 2023 Aug; 24(8): 1102–1109. Published online 2023 Apr 22. doi: 10.1093/ehjci/jead057
PMCID:
PMC10364618
AbstractArticlePDF–335K
15.
Lipoprotein(a) levels in children with suspected familial hypercholesterolaemia: a cross-sectional study
Lotte M de Boer, Barbara A Hutten, Aeilko H Zwinderman, Albert Wiegman
Eur Heart J. 2023 Apr 21; 44(16): 1421–1428. Published online 2022 Nov 16. doi: 10.1093/eurheartj/ehac660
Correction in:
Eur Heart J. 2023 Feb 21; 44(8): 679.
PMCID:
PMC10119030
AbstractArticlePDF–1.0M
16.
Association of Lipoprotein(a) and Hypertension in Primary Prevention of Cardiovascular Disease: The Multi-Ethnic Study of Atherosclerosis (MESA)
Rishi Rikhi, Harpreet S. Bhatia, Christopher L. Schaich, Nicklaus Ashburn, Michael Y. Tsai, Erin D. Michos, Parag Chevli, David Herrington, Sotirios Tsimikas, Michael D. Shapiro
Hypertension. Author manuscript; available in PMC 2024 Feb 1.
Published in final edited form as: Hypertension. 2023 Feb; 80(2): 352–360. Published online 2022 Dec 13. doi: 10.1161/HYPERTENSIONAHA.122.20189
PMCID:
PMC9983733
AbstractArticlePDF–448K
17.
Relationship of Low-Density Lipoprotein-Cholesterol and Lipoprotein(a) to Cardiovascular Risk –the Multi-Ethnic Study of Atherosclerosis (MESA)
Rishi Rikhi, Aziz Hammoud, Nicklaus Ashburn, Anna C. Snavely, Erin D. Michos, Parag Chevli, Michael Y. Tsai, David Herrington, Michael D. Shapiro
Atherosclerosis. Author manuscript; available in PMC 2023 Feb 25.
Published in final edited form as: Atherosclerosis. 2022 Dec; 363: 102–108. Published online 2022 Oct 8. doi: 10.1016/j.atherosclerosis.2022.10.004
PMCID:
PMC9964094
AbstractArticlePDF–942K
18.
Lipoprotein(a) in Atherosclerotic Diseases: From Pathophysiology to Diagnosis and Treatment
Stamatios Lampsas, Maria Xenou, Evangelos Oikonomou, Panteleimon Pantelidis, Antonios Lysandrou, Savvas Sarantos, Athina Goliopoulou, Konstantinos Kalogeras, Vasiliki Tsigkou, Athanasios Kalpis, Stavroula A. Paschou, Panagiotis Theofilis, Manolis Vavuranakis, Dimitris Tousoulis, Gerasimos Siasos
Molecules. 2023 Feb; 28(3): 969. Published online 2023 Jan 18. doi: 10.3390/molecules28030969
PMCID:
PMC9918959
AbstractArticlePDF–1.7M
19.
Lipoprotein(a) is associated with the onset but not the progression of aortic valve calcification
Yannick Kaiser, Janine E van der Toorn, Sunny S Singh, Kang H Zheng, Maryam Kavousi, Eric J G Sijbrands, Erik S G Stroes, Meike W Vernooij, Yolanda B de Rijke, S Matthijs Boekholdt, Daniel Bos
Eur Heart J. 2022 Oct 14; 43(39): 3960–3967. Published online 2022 Jul 23. doi: 10.1093/eurheartj/ehac377
PMCID:
PMC9840475
AbstractArticlePDF–6.3M
20.
Lipoprotein(a) levels and risk of adverse events after myocardial infarction in patients with and without diabetes
Angelo Silverio, Francesco Paolo Cancro, Marco Di Maio, Michele Bellino, Luca Esposito, Mario Centore, Albino Carrizzo, Paola Di Pietro, Anna Borrelli, Giuseppe De Luca, Carmine Vecchione, Gennaro Galasso
J Thromb Thrombolysis. 2022; 54(3): 382–392. Published online 2022 Sep 20. doi: 10.1007/s11239-022-02701-w
PMCID:
PMC9553824
AbstractArticlePDF–1.6M

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Filter your results:

Find related data

Recent activity

You are here: NCBI > Literature > PubMed Central (PMC)
Support Center